参考文献/References:
[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(6):573-611.
[2] KLEMM P,SCHULZ N,LANGE U,et al.Diagnostics and treatment of osteoporosis in 2025:an update on current guidelines[J].Inn Med(Heidelb),2025,66(6):603-614.
[3] 杨锋,张磊.原发性骨质疏松症中医诊疗方案解读[J].现代中医药,2023,43(2):20-23.
[4] MANGANO G,AVOLA M,BLATTI C,et al.Non-adherence to anti-osteoporosis medication:factors influencing and strategies to overcome it:a narrative review[J].J Clin Med,2022,12(1):14.
[5] LI Y D,LI W C,LEE K.Comparison of teriparatide and bisphosphonate in the treatment of postmenopausal osteoporosis:a meta-analysis[J].Asian J Surg,2024,16(24):02088.
[6] 林贤灿,陈桐莹,林燕平,等.原发性骨质疏松症的中医认识与探索[J].中国骨质疏松杂志,2023,29(6):870-874.
[7] 王阁,赵林华,张伟,等.重构本草——当归[J].长春中医药大学学报,2025,41(1):23-25.
[8] CHEN Y H,GUO Q S,DENG Q H,et al.The dynamic accumulation rules of chemical components in different medicinal parts of Angelica sinensis by GC-MS[J].Molecules,2022,27(14):4617.
[9] 吴娇,张驾龙,仝芳超,等.当归的化学成分、药理作用及临床应用[J].中医学报,2025,40(9):1917-1923.
[10] 班正涛,施明华,龚德飞,等.基于网络药理学探讨当归治疗骨质疏松症的分子机制[J].中医临床研究,2025,17(15):69-75.
[11] YUAN A,LIU C,FENG W,et al.Integrating network pharmacology,quantitative metabolic network analysis,in vitro experiments,and molecular dynamics to explore the mechanism of Angelica sinensis for regulating bone metabolism[J].Comb Chem High Throughput Screen,2025,28(6):1054-1071.
[12] 齐伟,刘建军,王凯,等.当归活性成分治疗骨关节炎的药理学机制研究进展[J].中国医院药学杂志,2024,44(14):1708-1714.
[13] LEE W C,GUNTUR A R,LONG F X,et al.Energy metabolism of the osteoblast:implications for osteoporosis[J].Endocr Rev,2017,38(3):255-266.
[14] 顾超,陈维凯,刘滔,等.骨髓间充质干细胞线粒体损伤影响其成骨分化的潜能[J].中国组织工程研究,2022,26(31):4921-4927.
[15] 王晓宁,许云腾,韩一旦,等.从肾藏精主骨探析绝经后骨质疏松症骨髓间充质干细胞成骨-成脂分化失衡的机制[J].中华中医药杂志,2021,36(6):3449-3452.
[16] 齐嵘嘉,肖含先之,汪子铃,等.当归多糖减轻5-氟尿嘧啶对骨髓基质细胞成骨分化的抑制[J].中国细胞生物学学报,2020,42(3):435-443.
[17] 廖锋,刘瑶,刘航航,等.当归多糖对高糖状态下大鼠骨髓间充质干细胞成骨向分化的影响[J].华西口腔医学杂志,2019,37(2):193-199.
[18] XIE X,LIU M,MENG Q.Angelica polysaccharide promotes proliferation and osteoblast differentiation of mesenchymal stem cells by regulation of long non-coding RNA H19:an animal study[J].Bone Joint Res,2019,8(7):323-332.
[19] 蔡林利,朱霞,陈雁.当归多糖对低氧环境中骨髓间充质干细胞成骨分化潜能的影响[J].广西医学,2024,46(5):727-730.
[20] 杨雷,郭岱琦,柳海峰,等.阿魏酸对大鼠成骨细胞增殖、碱性磷酸酶活性及骨保护素与骨活素mRNA表达的影响[J].中国中医药科技,2016,23(4):428-430.
[21] 高建林,陈珺,李兵,等.阿魏酸对体外培养的成骨细胞增殖、分化和矿化功能的影响[J].中国药理学通报,2016,32(10):1479-1480.
[22] 黄慧灵.阿魏酸延缓原代成骨细胞的衰老及对骨丢失的预防作用[D].广州:广东药科大学,2022.
[23] 刘宏璐.阿魏酸对高糖环境下MC3T3-E1细胞成骨能力的影响及相关机制研究[D].广州:南方医科大学,2022.
[24] 王凯,文皓楠,宋志靖,等.藁本内酯调控H型血管防治骨质疏松症的网络药理学与分子对接分析及动物实验研究[J].中国药理学通报,2025,41(3):583-591.
[25] 杨菲.基于雌激素受体探讨藁本内酯对骨形成的影响及其相关机制[D].南京:南京中医药大学,2019.
[26] 罗聪,黄肖华,陈洋洋,等.中药活性成分调控成骨细胞凋亡干预骨质疏松症的研究进展[J].广西中医药,2026,49(2):72-76.
[27] WANG D,LI J,FENG W,et al.Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression[J].J Cell Biochem,2019,120(11):18667-18677.
[28] 崔杰,李梦雨,刘雨彤,等.藁本内酯抑制RANKL诱导RAW264.7向破骨细胞分化及其与GPER相关机制[J].南京中医药大学学报,2021,37(4):514-520.
[29] XIN Z,FANG C,GU Y,et al.Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C-Src and inhibiting NF-κB,MAPK and AKT path-ways[J].J Cell Mol Med,2020,24(9):5122-5134.
[30] DOSS H M,SAMARPITA S,GANESAN R,et al.Ferulic-acid,a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway[J].Life Sci,2018,207:284-295.
[31] 王时誉,孙广江.炎症相关因素对骨质疏松症影响研究进展[J].中国骨质疏松杂志,2026,32(2):216-222.
[32] 韦子强,张雯雯,郭嘉亮,等.阿魏酸抑制p38 MAPK信号传导对巨噬细胞M1极化的作用[J].广东药科大学学报,2023,39(3):68-72.
[33] 欧玉琼.阿魏酸对高糖培养MC3T3-E1细胞增殖、分化及炎症因子表达的影响[D].广州:南方医科大学,2022.
[34] 那日苏,梁崧艺,衣仕瑜,等.氧化应激在骨质疏松症发生发展中的作用机制研究[J].内蒙古医学杂志,2025,57(3):312-316.
[35] 黄天一,陈婷婷,崔杰,等.阿魏酸抗成骨细胞凋亡作用及其GPR30相关性研究[J].南京中医药大学学报,2020,36(3):346-351.
[36] 邬钰,陈艳莉,陈胜柱,等.阿魏酸对过氧化氢诱导成骨细胞损伤的影响[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(2):140-147.
[37] WAGLE S,SIM H J,BHATTARAI G,et al.Supplemental ferulic acid inhibits total body irradiation-mediated bone marrow damage,bone mass loss,stem cell senescence,and hematopoietic defect in mice by enhancing antioxidant defense systems[J].Antioxidants(Basel),2021,10(8):1209.
[38] 庄超.当归多糖对大鼠软骨细胞氧化应激保护作用的实验研究[D].南京:南京医科大学,2017.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(06):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(06):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(06):16.